IRCT2014072618603N1已完成3 期
Adult Human Mesenchymal Stem Cells for the treatment of Steroid-Refractory Acute Graft-versus-Host Disease
Vice chancellor of research, Shiaz Univeisity of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 60 years（—）
- 性别
- All
入选标准
- •recipients of allogeneic hematopoietic stem cell transplantation; patients with refractory acute graft versus host disease; subjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study Exclusion criteria:
- •any abnormality in a vital sign (heart rate, respiratory rate, or blood pressure); patients with any conditions not suitable for the trial (investigators' decision)
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Application of Mesenchymal Stem Cells and full of plasma in the management of the burn wound in patients with large burn injury - Stem CellsEUCTR2012-001596-36-ESMIGUEL CASARES FERNÁNDEZ-ALVÉS
招募中
1 期
Cell therapy with use of mesenchymal stem cells in infertile women with Thin EndometriumIRCT20230222057500N1Tehran University of Medical Sciences10
进行中（未招募）
不适用
Mesenchymal stem cell based therapy for the treatment of osteogenesis imperfectaOsteogenesis imperfecta (OI) is a rare genetic disorder with increased bone fragility of varying severity. In the majority of patients the disease is caused by mutations in collagen type I. Severe OI is characterized by osteopenia, frequent fractures, progressive deformity, short stature, loss of mobility, chronic pain and can lead to premature death. At present a cure does not exist.EUCTR2012-002553-38-ESItziar Astigarraga Aguirre
进行中（未招募）
1 期
Mesenchymal stem cells for neonatal strokePerinatal arterial Ischemic Stroke (PAIS)EUCTR2014-001912-20-NLniversity Medical Center Utrecht, The Netherlands20
撤回
不适用
Application of mesenchymal stem cells in patients with end-stage renal diseaseNL-OMON34665Erasmus MC, Universitair Medisch Centrum Rotterdam16